No needles in sight as Novo succeeds with new capsule technology

Novo Nordisk has reached an important milestone in its partnership with US university MIT. Its new technology opens the doors to big opportunities, but the road ahead is long, says the VP of Novo Nordisk.

Photo: PR/Novo Nordisk

The pharmaceutical company Novo Nordisk has achieved somewhat of a milestone in its collaboration with the world-famous university, Massachusetts Institute of Technology (MIT).

A completely new type of technology has shown itself capable of breaking an essential barrier in pigs.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs